Medtronic to Buy Contego Medical in $380 Million Deal

By Colin Kellaher

 

Medtronic has agreed to buy Contego Medical, a privately held medical-device company focused on solutions for carotid artery disease and peripheral thrombectomy, in a $380 million deal that bolsters its portfolio of carotid technologies.

Medtronic on Monday said the deal includes Contego's recently FDA-approved Neuroguard IEP direct system, a transcarotid artery revascularization system with integrated embolic protection in addition to flow reversal.

The Galway, Ireland-based medical-technology company said it expects to complete the purchase, which includes potential post-acquisition payments, in the third quarter of its 2027 fiscal year, which began on April 25.

Medtronic announced an exclusive U.S. distribution agreement with Contego in January 2025.

 

Write to Colin Kellaher at colin.kellaher@wsj.com

 

(END) Dow Jones Newswires

November 16, 2026 07:25 ET (12:25 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.

Popular

Sponsor Center